{"product_id":"endotoxin-and-sepsis-9780471194323","title":"Endotoxin and Sepsis","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eProgress in Clinical and Biological Research, Volume 397\u003cbr\u003e \u003cbr\u003e ENDOTOXIN AND SEPSIS\u003cbr\u003e \u003cbr\u003e Molecular Mechanisms of Pathogenesis, Host Resistance, and Therapy\u003cbr\u003e \u003cbr\u003e Proceedings of the Fourth Conference of the International EndotoxinSociety Held in Nagoya, Japan, October 23-27, 1996\u003cbr\u003e \u003cbr\u003e Jack Levin, Matthew Pollack, Takashi Yokochi, and Masayasu Nakano,Editors\u003cbr\u003e \u003cbr\u003e Recent breakthroughs in our understanding of the molecular biologyof the human immune response have lead to important advances in therecognition and treatment of sepsis. Endotoxin and Sepsis:Molecular Mechanisms of Pathogenesis, Host Resistance, and Therapycompiles the latest basic and clinical research on many aspects ofsepsis, including sepsis\/SIRS. It provides researchers andclinicians with an up-to-date overview of the critical data andconcepts in this rapidly progressing field of inquiry.\u003cbr\u003e \u003cbr\u003e Featuring contributions by researchers and clinicians from aroundthe world, this book presents papers covering\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eEnzymes of Lipid A Biosynthesis: Target for the Design of New Antibiotics (C. Raetz).  \u003cp\u003eBiosynthesis of \u003ci\u003eEscherichia coli\u003c\/i\u003e 09 Polysaccharide and its Evolution (N. Kido).\u003c\/p\u003e \u003cp\u003eCore Structure, of Enterobacterial Lipopolysaccharides (O. Holst, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eUnique Structural and Biological Features of \u003ci\u003eHelicobacter pylori\u003c\/i\u003e Lipopolysaccharides (A. Moran \u0026amp; G. Aspinall).\u003c\/p\u003e \u003cp\u003eWhat We Know and Don't Know about the Chemical and Physical Structure of Lipopolysaccharides in Relation to Biological Activity (S. Müller-Loennies, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eRoles for LBP and Soluble Cd14 in Cellular Uptake of LPS (R. Tapping, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eStructure-Function Analysis of Soluble and Membrane-Bound CD14 (T. Kirkland \u0026amp; S. Viriyakosol).\u003c\/p\u003e \u003cp\u003eRoles of CD14 in LPS Signaling and Scavenging: Analysis of CD14-Transgenic and Non-Transgenic Mice and Rats in Response to LPS (S. Yamamoto, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eThe Role of Scavenger Receptors in LPS-Induced Macrophage Activation (T. Kirikae, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eThe CD11\/CD18 Integrins: Characterization of Three Novel LPS Signaling Receptors (R. Ingalls, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eThe Role of Tyrosine Kinases and MAP Kinases in LPS-Induced Signaling (A. DeFranco, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eCD14 Dependent and Independent Signaling Pathways in Murine Macrophages from Normal and CD14 \"Knockout\" (CD14KO) Mice Stimulated with LPS or Taxol (S. Vogel, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eADP-Ribosylation: Role in LPS-Induced Phosphorylation of Two Cytosolic Proteins (p36\/38) in Monocytes (S. Hauschildt, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eCD14 Dependent Mechanisms of Cell Activation (J. Han, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eCytokine Regulation of Inducible Nitric Oxide Synthase in Vascular Smooth Muscle Cells (J. Cohen, \u003ci\u003eet al.N).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDetoxification of Lipopolysaccharide by Lysozyme (N. Ohno, et al.).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eRole of Hepatocytes in the Clearance of Lipopolysaccharide and its Clinical Significance (K. Tanikawa, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eAntibiotic-Mediated Release of Endotoxin and the Pathogenesis of Gram-Negative Sepsis (D. Morrison).\u003c\/p\u003e \u003cp\u003eMolecular Mechanisms Responsible for Endotoxin Tolerance (B. Yoza, \u003ci\u003eet al.N).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eEndotoxin Tolerance Alters Macrophage Membrane Regulatory G Proteins (M. Makhlouf, et al.).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eLipopolysaccharide (LPS) Antibodies Regulate Cellular Uptake of LPS and LPS Induced Proinflammatory Responses (C. Ohl \u0026amp; M. Pollack).\u003c\/p\u003e \u003cp\u003eApoptotic Cell Death in Response to LPS (T. Yokochi, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eStimulation of Human T Lymphocytes by Lipopolysaccharide (LPS) in the Presence of Autologous and Heterologous Monocytes (T. Mattern, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eRole of CD14 in Infection: Studies in CD14-Deficient Mice (A. Haziot, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eReconciling the Concepts of Endotoxin Sensitization and Tolerance (M. Freudenberg, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eProduction of Nontoxic Lipid A by Chemical Modification and its Antagonistic Effect on LPS Activity (K. Tanamoto).\u003c\/p\u003e \u003cp\u003eThe Protective Effect of Prostaglandin E\u003csub\u003e1\u003c\/sub\u003e on Endotoxin-Induced Hepatocyte Injury (H. Shimada, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eNatural and Synthetic LPS and Lipid A Analogs or Partial Structures that Antagonize or Induce Tolerance to LPS (N. Qureshi, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eThe Molecular Basis for Therapeutic Concepts Utilizing CD14 (F. Stelter, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eNatural and Synthetic Polypeptides that Recoggnize the Conserved Lipid A Binding Site of Lipoplysaccharides (M. Porro, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003ePrevention of Endotoxin Shock through Targeting Leukocytes Adhesion Molecules (H. Higashi, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eSuppression of TNF and other Proinflammatory Cytokines by the Tetravalent Guanylhydrazone CNI-1493 (K. Tracey).\u003c\/p\u003e \u003cp\u003eInteraction of Lipopolysaccharide with a Mammalian Lyso-phosphatidate Acyltransferase (LPAAT) Tranfected into \u003ci\u003eE.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003ecoli\u003c\/i\u003e, and Effect of Lisofylline on LPAAT Transfected into Mammalian Cells (S. Bursten).\u003c\/p\u003e \u003cp\u003eRole of Nitric Oxide and Reactive Oxygen Species in Endotoxin Shock (T. Yoshikawa, et al.).\u003c\/p\u003e \u003cp\u003eThe Role of Interleukin 6 in Endotoxin-Induced Inflammatory Responses (T. van der Poll \u0026amp; S. van Deventer).\u003c\/p\u003e \u003cp\u003eThe Pathogenic Role of LBP in Gram-Negative Sepsis and Septic Shock (D. Heumann, et al.).\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402523943255,"sku":"9780471194323","price":999.99,"currency_code":"GBP","in_stock":false}],"url":"https:\/\/bookcurl.com\/products\/endotoxin-and-sepsis-9780471194323","provider":"Book Curl","version":"1.0","type":"link"}